Skljarevski V - Search Results

1

Monoclonal antibodies for chronic pain: a practical review of mechanisms and clinical applications.

Yeh JF, Akinci A, Al Shaker M, Chang MH, Danilov A, Guileen R, Johnson K, Kim YC, El-Shafei A, Skljarevski V, Duenas H, Tassanawipas W. Yeh JF, et al. Among authors: skljarevski v. Mol Pain. 2017 Jan-Dec;13:1744806917740233. doi: 10.1177/1744806917740233. Mol Pain. 2017. PMID: 29056066 Free PMC article. Review.

2

Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.

Gao Y, Guo X, Han P, Li Q, Yang G, Qu S, Yue L, Wang CN, Skljarevski V, Dueñas H, Raskin J, Gu L. Gao Y, et al. Among authors: skljarevski v. Int J Clin Pract. 2015 Sep;69(9):957-66. doi: 10.1111/ijcp.12641. Epub 2015 May 4. Int J Clin Pract. 2015. PMID: 25939897 Free PMC article. Clinical Trial.

3

Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study.

Wang G, Bi L, Li X, Li Z, Zhao D, Chen J, He D, Wang CN, Dueñas H, Skljarevski V, Yue L. Wang G, et al. Among authors: skljarevski v. Osteoarthritis Cartilage. 2017 Jun;25(6):832-838. doi: 10.1016/j.joca.2016.12.025. Epub 2016 Dec 31. Osteoarthritis Cartilage. 2017. PMID: 28043937 Free article. Clinical Trial.

4

Clinical meaningfulness of duloxetine's effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase 3 randomized trial.

Yue L, Luo S, Wang Y, Wang CN, Dueñas HJ, Skljarevski V. Yue L, et al. Among authors: skljarevski v. Open Access Rheumatol. 2019 Mar 21;11:67-76. doi: 10.2147/OARRR.S193044. eCollection 2019. Open Access Rheumatol. 2019. PMID: 30962729 Free PMC article.

5

Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data.

Wang G, Bi L, Li X, Li Z, Zhao D, Chen J, He D, Wang CN, Wu T, Dueñas H, Skljarevski V, Yue L. Wang G, et al. Among authors: skljarevski v. BMC Musculoskelet Disord. 2019 Apr 22;20(1):174. doi: 10.1186/s12891-019-2527-y. BMC Musculoskelet Disord. 2019. PMID: 31010413 Free PMC article. Clinical Trial.

6

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.

Skljarevski V, Oakes TM, Zhang Q, Ferguson MB, Martinez J, Camporeale A, Johnson KW, Shan Q, Carter J, Schacht A, Goadsby PJ, Dodick DW. Skljarevski V, et al. JAMA Neurol. 2018 Feb 1;75(2):187-193. doi: 10.1001/jamaneurol.2017.3859. JAMA Neurol. 2018. PMID: 29255900 Free PMC article. Clinical Trial.

7

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, Jensen MP, Katz NP, Raja SN, Rappaport BA, Rowbotham MC, Backonja MM, Baron R, Bellamy N, Bhagwagar Z, Costello A, Cowan P, Fang WC, Hertz S, Jay GW, Junor R, Kerns RD, Kerwin R, Kopecky EA, Lissin D, Malamut R, Markman JD, McDermott MP, Munera C, Porter L, Rauschkolb C, Rice ASC, Sampaio C, Skljarevski V, Sommerville K, Stacey BR, Steigerwald I, Tobias J, Trentacosti AM, Wasan AD, Wells GA, Williams J, Witter J, Ziegler D. Dworkin RH, et al. Among authors: skljarevski v. Pain. 2012 Jun;153(6):1148-1158. doi: 10.1016/j.pain.2012.03.003. Epub 2012 Apr 9. Pain. 2012. PMID: 22494920

8

5-HT1F receptor agonists in acute migraine treatment: a hypothesis.

Ramadan NM, Skljarevski V, Phebus LA, Johnson KW. Ramadan NM, et al. Among authors: skljarevski v. Cephalalgia. 2003 Oct;23(8):776-85. doi: 10.1046/j.1468-2982.2003.00525.x. Cephalalgia. 2003. PMID: 14510923 Review.

9

Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.

Ament M, Day K, Stauffer VL, Skljarevski V, Rettiganti M, Pearlman E, Aurora SK. Ament M, et al. Among authors: skljarevski v. J Headache Pain. 2021 Feb 6;22(1):6. doi: 10.1186/s10194-021-01215-9. J Headache Pain. 2021. PMID: 33549036 Free PMC article. Clinical Trial.

10

Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.

Skljarevski V, Zhang S, Chappell AS, Walker DJ, Murray I, Backonja M. Skljarevski V, et al. Pain Med. 2010 May;11(5):648-57. doi: 10.1111/j.1526-4637.2010.00836.x. Epub 2010 Apr 13. Pain Med. 2010. PMID: 20546509 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page